| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | Chief Financial Officer | Common Stock | 94.8K | $1.6M | $16.83 | Jan 6, 2025 | Direct |
| Protara Therapeutics, Inc. | Chief Financial Officer | Common Stock | 20.7K | $39.5K | $1.91 | Jul 15, 2022 | Direct |
| Protara Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 84.8K | Jan 3, 2022 | Direct | ||
| Cartesian Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 64.6K | Jan 2, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | Jan 3, 2025 | 2 | -$134K | 4 | Jan 7, 2025 | Chief Financial Officer |
| RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2025 | 2 | $0 | 4 | Jan 6, 2025 | Chief Financial Officer |
| RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Chief Financial Officer |
| SELB | Cartesian Therapeutics, Inc. | Nov 13, 2023 | 1 | -$988K | 4 | Nov 15, 2023 | Chief Financial Officer |
| SELB | SELECTA BIOSCIENCES INC | Nov 28, 2022 | 1 | $0 | 4 | Nov 30, 2022 | Chief Financial Officer |
| SELB | SELECTA BIOSCIENCES INC | Nov 28, 2022 | 0 | $0 | 3 | Nov 30, 2022 | Chief Financial Officer |
| TARA | Protara Therapeutics, Inc. | Jul 15, 2022 | 1 | -$15.9K | 4 | Jul 19, 2022 | Chief Financial Officer |
| TARA | Protara Therapeutics, Inc. | Jan 3, 2022 | 2 | $0 | 4 | Jan 5, 2022 | Chief Financial Officer |